Skip to main content

US ClosedU.S. Closed

PYPD: PolyPid Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions.

52W Range

75thpctl

Volume

0.36×avg

Market Cap

96.75MUSD

P/E Ratio

-3.4TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

PolyPid Ltd.

PYPDNASDAQ Global Market·USD·Closed

PolyPid Ltd.

PYPDNASDAQ·USD·Closed

$5.07

−0.98%

$5.07

−$0.05 (0.98%)

52W Range

75thpctl

Volume

0.36×avg

Mkt Cap

96.75MUSD

P/E

-3.4TTM

Div Yield

–ann